Actinium Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Actinium Pharmaceuticals, Inc. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 17 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 0 trademarks are registered and 7 are pending. The owner is based in New York, NY.

501 Fifth Avenue

New York, NY 10017

24 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Actinium Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (17 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (16 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Actinium Pharmaceuticals, Inc. have?

Actinium Pharmaceuticals, Inc. has 24 U.S. trademarks filed with the USPTO. Of these, 7 pending, 15 abandoned, 2 cancelled.

What trademark classes does Actinium Pharmaceuticals, Inc. file in?

Actinium Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Actinium Pharmaceuticals, Inc.'s trademark registration success rate?

Actinium Pharmaceuticals, Inc. has a 0% trademark registration rate, with 0 out of 17 resolved applications resulting in successful registration. Currently, 7 applications are pending review.